New postings and analysis from Health Affairs, the leading journal of health policy. Health Affairs publishes new research each week online at www.healthaffairs.org. For more information, contact Chris Fleming at 301-347-3944.
Emerging Lessons From The Drug Effectiveness Review Project|
In an article published June 6 on the Health Affairs Web site, Peter Neumann provides a comprehensive review of the issues facing the Drug Effectiveness Review Project (DERP), a collaboration of fifteen states and two private organizations led by former Oregon governor John Kitzhaber (D). In four Perspectives on Neumann's paper:
DERP staffers Mark Gibson and John Santa, MD, say the DERP avoids cost-effectiveness analysis because of "methodological uncertainties," but states factor in costs when they use the DERP's findings in their Medicaid decision making;
Newell McElwee and other officials of the drugmaker Pfizer Inc. warn that DERP reviews must be used with caution in making coverage determinations to avoid hurting patients who differ from the average;
Alan Heaton, director of pharmacy for Blue Cross and Blue Shield of Minnesota, notes that using evidence-based principles to pick superior products within drug classes risks giving manufacturers of anointed products unwarranted pricing leverage;
and Steve Findlay, managing editor of Consumer Reports Best Buy Drugs, notes that his online project publishes DERP findings alongside cost information and chooses "best buy" drugs using both objective data and peer reviewers' subjective judgments.
Mental Health Spending Yields Good Return In Aggregate, Says Researcher
Trends in mental health spending during the 1990s broadly track trends in overall health care spending, Benjamin Druss writes in the May/June issue of Health Affairs. Like overall spending, mental health spending appears to be yielding a good return in the aggregate, but vulnerable populations and areas of waste and poor quality remain concerns. Druss reports that, between 1990-91 and 2003, the proportion of the population receiving mental health services rose from 12.2 to 20.1 percent, almost entirely due to increases in the use of psychotropic drugs.
Print editions of Health Affairs may be ordered for $35 each from Health Affairs' Customer Service at 301-347-3900 or online at www.healthaffairs.org/1330_issue.php.
ABOUT HEALTH AFFAIRS:
Health Affairs, published by Project HOPE, is the leading journal of health policy. The peer-reviewed journal appears bimonthly in print with additional online-only papers published weekly as Health Affairs Web Exclusives at www.healthaffairs.org. The full text of each Health Affairs Web Exclusive is available free of charge to all Web site visitors for a two-week period following posting, after which it switches to pay-per-view for nonsubscribers. The abstracts of all articles are free in perpetuity. Web Exclusives are supported in part by a grant from the Commonwealth Fund.
Subscribe today for full online access to Health Affairs--"the bible of health policy" (Washington Post, January 12, 2005).
FREE FROM HEALTH AFFAIRS
Be the first to see what's new in health policy.
- Sign up for Web Exclusive e-mail alerts from Health Affairs
NEW! Receive Health Affairs' headlines via RSS feed.
Health Affairs gratefully acknowledges the
support of Health Care Update News Service in the dissemination of this